Results 181 to 190 of about 18,298 (262)

A case of malignant fibrous histiocytoma in the maxilla

open access: yesAsian Journal of Surgery
Xin-Rui Ma   +3 more
doaj   +1 more source

Advances in Targeting Central Cholinergic Dysfunction for Neurodegenerative Diseases: From Pharmacotherapy to Neuromodulation

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 9, September 2026.
This review charts the evolution of cholinergic therapies for neurodegenerative diseases—from classical acetylcholinesterase inhibitors (AChEIs) providing symptomatic relief to precision multi‐target drugs and neuromodulation (VNS, DBS, NIBS) that restore dysfunctional circuits. Emerging gene therapy, cell regeneration, and advanced cholinergic imaging
Lei Lei   +4 more
wiley   +1 more source

Taurine and Metabolic Diseases: Molecular Mechanisms and Therapeutic Implications

open access: yesFood Frontiers, Volume 7, Issue 5, September 2026.
The dietary sources of taurine, as well as its protective effects and mechanisms in metabolism‐related diseases and metabolic disorder–associated ocular and cerebral injuries. ABSTRACT Taurine (Tau) is a sulfur‐containing amino acid prevalent in animal tissues and primarily acquired through dietary sources.
Xiaojie Ma, Zhijian Rao, Lifang Zheng
wiley   +1 more source

Pathological fracture following minimal trauma as the initial presentation of parathyroid carcinoma-associated hyperparathyroidism in a young man: a case report. [PDF]

open access: yesFront Endocrinol (Lausanne)
Vuksanović M   +5 more
europepmc   +1 more source

[Primary multiple neoplasms of the oral cavity, jaws and face].

open access: yesWiadomosci lekarskie (Warsaw, Poland : 1960), 1976
H, Krysiak, A, Wiktor
openaire   +1 more source

Langerhans Cell Histiocytosis in Adults: A Canadian Multicenter Case Series

open access: yesHematological Oncology, Volume 44, Issue 5, September 2026.
ABSTRACT Langerhans cell histiocytosis (LCH) is a rare clonal myeloid neoplasm. Canadian data on clinical characteristics, molecular profile, and treatment outcomes is limited. This study aims to report the initial experience of a Canadian rare diseases program, reflecting “real‐world” diagnostic pathways, referral patterns, and treatment heterogeneity
Stephanie Quon   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy